Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine.
作者信息
Banerjee Sanchari, Sandhu Michael, Tonzi Erin, Tambe Ajay, Gambhir Harvir Singh
机构信息
Department of Internal Medicine, SUNY UPSTATE Medical University, Syracuse, NY.
Medicine Program, State University of New York Upstate Medical University, Syracuse, NY.
出版信息
Am J Ther. 2021 Aug 20;28(5):e604-e606. doi: 10.1097/MJT.0000000000001431.
Abstract
摘要
相似文献
1
Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine.与Ad26.COV2.S（杨森；强生）疫苗相关的免疫介导性血小板减少症。
Am J Ther. 2021 Aug 20;28(5):e604-e606. doi: 10.1097/MJT.0000000000001431.
2
A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson).1剂次Ad26.COV2.S疫苗（杨森/强生公司）接种后发生疫苗诱导的免疫性血小板减少症和血栓形成综合征的病例报告
Therapie. 2022 Nov-Dec;77(6):734-737. doi: 10.1016/j.therap.2022.01.014. Epub 2022 Jan 31.
3
Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).接种新型冠状病毒疫苗（ChAdOx1 nCoV-19）后发生免疫性血小板减少性紫癜
Blood. 2021 Sep 16;138(11):996-999. doi: 10.1182/blood.2021012790.
4
Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.在首次发生免疫性血小板减少性紫癜后成功进行mRNA SARS-CoV-2疫苗再次接种。
Platelets. 2022 May 19;33(4):652-653. doi: 10.1080/09537104.2022.2044463. Epub 2022 Feb 28.
5
Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.疫苗诱导的免疫性血小板减少症和血栓形成：英国国家卫生与临床优化研究所指南摘要
BMJ. 2021 Oct 1;375:n2195. doi: 10.1136/bmj.n2195.
6
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.美国 2021 年 4 月：在报告接种强生（Johnson & Johnson）新冠疫苗的人群中出现血栓性血小板减少综合征后，免疫实践咨询委员会更新了强生疫苗的使用建议。
MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):651-656. doi: 10.15585/mmwr.mm7017e4.
7
COVID-19 vaccine induced prothrombotic immune thrombocytopenia.新冠病毒疫苗诱导的血栓性免疫性血小板减少症
Eur Heart J. 2021 Aug 31;42(33):3206. doi: 10.1093/eurheartj/ehab237.
8
Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.辉瑞-BioNTech BNT162b2 mRNA新冠疫苗接种后出现免疫性血小板减少症
Isr Med Assoc J. 2021 Jun;23(6):341.
9
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.美国 2021 年 3 月 2 日至 4 月 21 日 Ad26.COV2.S 疫苗接种后出现脑静脉窦血栓形成伴血小板减少的病例报告。
JAMA. 2021 Jun 22;325(24):2448-2456. doi: 10.1001/jama.2021.7517.
10
Immune Thrombocytopenic Purpura (ITP) Triggered by COVID-19 Infection and Vaccination.由新冠病毒感染和疫苗接种引发的免疫性血小板减少性紫癜（ITP）
Isr Med Assoc J. 2021 Jun;23(6):378-380.
引用本文的文献
1
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.COVID-19 疫苗接种相关免疫性血小板减少性紫癜：一项系统评价。
Eur J Haematol. 2023 Apr;110(4):335-353. doi: 10.1111/ejh.13917. Epub 2022 Dec 30.
2
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years.美国 12 至 64 岁 COVID-19 疫苗接种者安全结局的实时监测。
Vaccine. 2022 Oct 26;40(45):6481-6488. doi: 10.1016/j.vaccine.2022.09.060. Epub 2022 Sep 27.
3
A Systematic Review of Reported Cases of Immune Thrombocytopenia after COVID-19 Vaccination.新型冠状病毒肺炎疫苗接种后免疫性血小板减少症报告病例的系统评价
Vaccines (Basel). 2022 Sep 1;10(9):1444. doi: 10.3390/vaccines10091444.
4
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
5
Comparison of replicating and nonreplicating vaccines against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的复制型疫苗与非复制型疫苗的比较。
Sci Adv. 2022 Aug 26;8(34):eabm8563. doi: 10.1126/sciadv.abm8563. Epub 2022 Aug 24.
6
Refined Capsid Structure of Human Adenovirus D26 at 3.4 Å Resolution.人腺病毒 D26 的精细衣壳结构在 3.4 Å 分辨率下。
Viruses. 2022 Feb 17;14(2):414. doi: 10.3390/v14020414.
Zotero 插件